S100P is a ferroptosis suppressor to facilitate hepatocellular carcinoma development by rewiring lipid metabolism

Min Yang(Shandong University), Bo Chu(Shandong University)

Nature Communications

January 8, 2025

10.1038/s41467-024-55785-8

Cited by 33

Related Papers

Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth

|Advanced Science|2023|148

HDAC10 switches NLRP3 modification from acetylation to ubiquitination and attenuates acute inflammatory diseases

|Cell Communication and Signaling|2024|13

Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury

|Advanced Science|2025|5

HDAC10 negatively regulates NLRP3 inflammasome activation by switching NLRP3 modification from acetylation to ubiquitination

|Research Square|2023|1

Preparation and preliminary biological evaluation of [<sup>18</sup>F]AlF-labeled Albumin-binding agent modified PARP-targeted imaging probe

|Nuclear Techniques|2025|1